Validation of a Multi-gene Test for Lung Cancer Risk
The purpose of this study is to determine the validity of a multi-gene Lung Cancer Risk Test (LCRT). In the process, the investigators will establish a bank of NBEC samples and corresponding blood samples from individuals demographically at increased risk for lung cancer.
Checked against the public recordLast updated Jun 10, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- University of Toledo Health Science Campus
- Interventions being studied
- Genetic: Lung Cancer Risk Test
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * 20 or more pack year smoking history * clinical need for diagnostic bronchoscopy or consent to study driven bronchoscopy Exclusion Criteria: * Lung Cancer within 3 months after the date of enrollment
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- National Jewish HealthDenver, Colorado
- University of MichiganAnn Arbor, Michigan
- Henry FordDetroit, Michigan
- Mayo ClinicRochester, Minnesota
- Cleveland Clinic FoundationCleveland, Ohio
- Ohio State UniversityColumbus, Ohio
- The Toledo HospitalToledo, Ohio
- Mercy St. Vincent Medical CenterToledo, Ohio
- University of Toledo, Health Science CampusToledo, Ohio
- Medical University of South CarolinaCharleston, South Carolina
- Tennessee Valley Veterans Admin.Nashville, Tennessee
- VanderbiltNashville, Tennessee
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 10, 2025. Always confirm current availability with the study team.